Gel-Based Matrix Technology for Diverse Applications

This inventive concept leverages the core technology of nutraceutical gels to develop novel applications in athletic performance enhancement, inflammation reduction, skin rejuvenation, veterinary immune response enhancement, and pharmaceutical treatments for respiratory diseases.

The original patent disclosed nutraceutical gels with immune modulators and oligomeric proanthocyanidins for human consumption. However, these gels were limited to the nutraceutical industry. This inventive concept addresses the problem of underutilization of the core technology by expanding its application to various industries, including sports, cosmetics, veterinary, and pharmaceuticals.

The new claims describe systems, methods, and compositions that utilize the gel-based matrix technology to deliver immune modulators and oligomeric proanthocyanidins in diverse applications. For example, the athletic performance enhancement system comprises a gel-based matrix containing an immune modulator and an oligomeric proanthocyanidin, which enhances athletic performance by boosting the immune system. Similarly, the cosmetic product for skin rejuvenation utilizes the gel-based matrix to deliver the immune modulator and oligomeric proanthocyanidin, promoting skin health and rejuvenation.

The new claims introduce novel applications of the gel-based matrix technology, which are non-obvious and unexpected from the original patent. The inventive step lies in recognizing the potential of the core technology to solve problems in unrelated industries and developing new compositions, systems, and methods to achieve these applications.

Alternative embodiments of the inventive concept could include different types of immune modulators, oligomeric proanthocyanidins, or gel-based matrices. Variations could also include different methods of administration, such as topical, oral, or injectable forms.

The inventive concept has significant commercial potential in various industries, including sports, cosmetics, veterinary, and pharmaceuticals. The target market includes companies developing products for athletic performance enhancement, skin rejuvenation, veterinary health, and respiratory disease treatments. The potential market size is substantial, with opportunities for partnerships, licensing, and new product development.